Login to Your Account

J&J Buying Tibotec-Virco For $320 In Cash And Debt

By James Etheridge

Wednesday, March 27, 2002
PARIS Johnson & Johnson signed a definitive agreement to acquire all of the assets of Tibotec-Virco NV for $320 million in cash and debt. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription